Lucid Diagnostics (LUCD) Change in Accured Expenses (2020 - 2026)

Lucid Diagnostics (LUCD) has 7 years of Change in Accured Expenses data on file, last reported at -$519000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses rose 31.35% year-over-year to -$519000.0; the trailing twelve-month figure through Mar 2026 stood at $127000.0 (down 87.61% YoY), and the FY2025 full-year result was -$110000.0, up 89.13% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at -$519000.0, down from $443000.0 in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $7.7 million in Q4 2022 and bottomed at -$2.9 million in Q4 2023.
• The 5-year median for Change in Accured Expenses is $113000.0 (2022), against an average of $495588.2.
• The widest annual swing landed in 2022, when Change in Accured Expenses slumped 667.06%; it then surged 2260.18% in 2023.
• A 5-year view of Change in Accured Expenses shows it stood at $7.7 million in 2022, then plunged by 138.3% to -$2.9 million in 2023, then jumped by 128.1% to $824000.0 in 2024, then tumbled by 46.24% to $443000.0 in 2025, then slumped by 217.16% to -$519000.0 in 2026.
• The last three Change in Accured Expenses figures came in at -$519000.0 (Q1 2026), $443000.0 (Q4 2025), and -$146000.0 (Q3 2025), per Business Quant data.

Peer Comparison